TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Imugene ( (AU:IMU) ) is now available.
Imugene Limited has released a disclaimer regarding its presentation for the Annual General Meeting in November 2025. The company emphasizes that the information provided does not constitute personal investment advice and should not be solely relied upon for making investment decisions. Stakeholders are advised to seek professional investment advice, as the presentation does not account for individual investment objectives or financial situations. Imugene also highlights that the presentation is not an offer to sell or solicit securities in jurisdictions where such actions would be unlawful, including the United States.
The most recent analyst rating on (AU:IMU) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Imugene stock, see the AU:IMU Stock Forecast page.
More about Imugene
Average Trading Volume: 2,518,499
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$102.5M
For a thorough assessment of IMU stock, go to TipRanks’ Stock Analysis page.